Study guide

5.6 ACLS Algorithms & Emergency Medications in the EP Lab

Registered Cardiac Electrophysiology Specialist RCES

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pre-Procedural Assessment & Patient Preparation

1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping

2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations

2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination

3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety

3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure

4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring

4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring

5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs

5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab

6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals

6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction

7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods

7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology

8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias

8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria

9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition

9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk

10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics

10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)

11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints

11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation

12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing

12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)

13 Chapter 13: CIED Interrogation, Programming & Troubleshooting

13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing

14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies

14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism

15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management

15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover

5.6 ACLS Algorithms & Emergency Medications in the EP Lab

Key Takeaways Explain This Topic AI

High-quality CPR means 100-120 compressions per minute at 2-2.4 inches depth with full recoil, minimal interruptions, and rhythm checks every 2 minutes.

Only ventricular fibrillation and pulseless ventricular tachycardia are shockable; asystole and pulseless electrical activity are treated with CPR and epinephrine.

Epinephrine 1 mg IV every 3-5 minutes is used in every arrest rhythm; amiodarone 300 mg then 150 mg or lidocaine is added for refractory shockable rhythms.

Synchronized cardioversion times the shock to the R wave to avoid the vulnerable period; unsynchronized defibrillation is used for VF and pulseless polymorphic VT.

Intravenous magnesium sulfate is the specific treatment for torsades de pointes even when the serum magnesium level is normal.

Last updated: September 2026

5.6 ACLS Algorithms & Emergency Medications in the EP Lab

The EP lab is the one place in the hospital where ventricular fibrillation is induced on purpose. CCI names Advanced Cardiac Life Support (ACLS) , Basic Life Support (BLS) , and emergency procedures and equipment in its published knowledge list, and task D8 requires assisting with management of procedural complications including emergency pacing.

1. High-Quality CPR

  • Element Standard
  • Rate 100-120 compressions per minute
  • Depth (adult) 2 to 2.4 inches (5-6 cm)
  • Recoil Full chest recoil between compressions
  • Interruptions Less than 10 seconds , including for rhythm checks
  • Compression fraction Target > 60% of arrest time spent compressing
  • Ventilation, no advanced airway 30:2 compression-to-ventilation
  • Ventilation, advanced airway 1 breath every 6 seconds (10/min) with continuous compressions
  • Compressor rotation Every 2 minutes with the rhythm check

EtCO₂ < 10 mmHg suggests inadequate compressions ; an abrupt rise toward normal suggests return of spontaneous circulation

In the EP lab three modifications apply. Compressions must not dislodge intracardiac catheters, so catheters are withdrawn to a safe position or removed if the arrest is prolonged. The fluoroscopy C-arm is swung clear immediately so it does not obstruct compressions or defibrillation. And because the patient is draped and often sedated, the team leader must explicitly assign airway, compressions, defibrillator, medications, and documentation rather than assume the usual code-team roles exist.

  • 2. The Cardiac Arrest Algorithm Unresponsive, no pulse
  • |
  • Start CPR, attach monitor
  • |
  • -----------------------------
  • | |
  • SHOCKABLE NON-SHOCKABLE
  • VF / pulseless VT Asystole / PEA
  • | |
  • DEFIBRILLATE CPR 2 min
  • CPR 2 min Epinephrine 1 mg ASAP,
  • Epinephrine 1 mg then q3-5 min
  • q3-5 min Treat reversible causes
  • Amiodarone 300 mg |
  • (or lidocaine) Rhythm check q2 min
  • Treat reversible causes

Shockable rhythms are ventricular fibrillation and pulseless ventricular tachycardia only. Asystole and pulseless electrical activity are never shocked ; treatment is compressions, epinephrine, and reversal of the underlying cause.

Reversible causes — the Hs and Ts , with their EP-lab-specific flavors:

  • Hs Ts
  • H ypovolemia (occult retroperitoneal bleed) T ension pneumothorax (subclavian puncture)
  • H ypoxia (over-sedation) T amponade, cardiac ( perforation — the most likely cause in this lab )
  • H ydrogen ion (acidosis) T oxins (local anesthetic, antiarrhythmic proarrhythmia)
  • H ypo-/hyperkalemia T hrombosis, pulmonary
  • H ypothermia T hrombosis, coronary (air embolism into the RCA)

In an EP lab arrest the first two considerations are almost always tamponade and hypoxia from sedation , and the fastest diagnostic tool for the first is the intracardiac echo catheter already in the right atrium.

3. Defibrillation Versus Synchronized Cardioversion

  • Defibrillation (unsynchronized) Synchronized cardioversion
  • Timing Immediate, any point in the cycle Synchronized to the R wave

Indication VF, pulseless VT, polymorphic VT with a pulse that is too disorganized to synchronize Unstable SVT, atrial fibrillation, atrial flutter, monomorphic VT with a pulse

Why No organized R wave to track Avoids delivering energy in the vulnerable period of the T wave, which would induce VF

Biphasic energy 120-200 J (device-specific), escalating AF 120-200 J; flutter and SVT 50-100 J; monomorphic VT 100 J

The most important trap: attempting to synchronize on a disorganized polymorphic rhythm causes the defibrillator to fail to discharge because it cannot find an R wave. If the patient is pulseless or the rhythm is polymorphic and unstable, switch to unsynchronized defibrillation.

Pad placement is anterolateral by default, or anteroposterior when the anterior chest is occupied by a sterile field, an implanted device, or when atrial defibrillation is anticipated. Pads are placed at least 8 cm from an implanted generator , and the device is fully interrogated after any external shock.

4. The Emergency Drug Set

Drug Dose Indication Mechanism

Epinephrine 1 mg IV/IO q3-5 min (arrest); 2-10 mcg/min infusion (bradycardia/hypotension) All arrest rhythms α₁ vasoconstriction raises coronary perfusion pressure; β₁ inotropy/chronotropy

Amiodarone 300 mg IV push , then 150 mg for refractory VF/pVT; 150 mg over 10 min for stable VT Refractory shockable rhythms Multi-channel: K⁺, Na⁺, Ca²⁺, beta blockade

Lidocaine 1-1.5 mg/kg, then 0.5-0.75 mg/kg Alternative to amiodarone Class IB Na⁺ channel blocker, ischemic tissue selective

Magnesium sulfate 1-2 g IV over 5-20 min Torsades de pointes Stabilizes membrane, suppresses early afterdepolarizations

Atropine 1 mg IV q3-5 min, max 3 mg Symptomatic bradycardia Antimuscarinic — blocks vagal tone at the SA and AV node

Dopamine 5-20 mcg/kg/min Bradycardia/hypotension Dose-dependent dopaminergic, β, then α effect

Adenosine 6 mg rapid push, then 12 mg Regular narrow-complex SVT Transient AV nodal block via A₁ receptor and IKACh

Calcium chloride/gluconate 1 g IV Hyperkalemia, calcium blocker overdose Membrane stabilization

Sodium bicarbonate 1 mEq/kg Hyperkalemia, sodium channel blocker toxicity, prolonged arrest with acidosis Alkalinization, sodium loading

  • Naloxone 0.04-0.4 mg titrated Opioid-induced respiratory arrest µ-receptor antagonist
  • Protamine 1 mg per 100 units active heparin Heparin reversal in tamponade Binds and neutralizes heparin

Atropine's critical limitation is tested constantly: it acts at the AV node , so it is ineffective — and can be harmful — in infranodal (Mobitz II or complete heart block with a wide escape) , where accelerating the sinus rate simply increases the number of blocked impulses and can worsen the ventricular rate. Those patients need transcutaneous pacing or an isoproterenol/epinephrine infusion while a temporary transvenous wire is placed.

Atropine is also ineffective in a transplanted (denervated) heart , which has no vagal innervation to block.

5. Bradycardia and Tachycardia in the Lab

Symptomatic bradycardia (hypotension, altered mental status, shock, ischemic chest pain, acute heart failure):

Atropine 1 mg IV, repeat every 3-5 minutes to a maximum of 3 mg.

If ineffective: transcutaneous pacing , and/or dopamine 5-20 mcg/kg/min or epinephrine 2-10 mcg/min .

Prepare for transvenous pacing — which in the EP lab means a catheter is often already in the right ventricle and can be connected to the stimulator for immediate emergency pacing.

That last point is a genuine EP lab advantage and a testable one: emergency pacing through an existing RV diagnostic catheter is faster than either transcutaneous or new transvenous access, provided output is set well above threshold and the connection is verified.

Tachycardia with a pulse: the first question is always stable or unstable . Instability — hypotension, altered mental status, shock, ischemic chest pain, acute heart failure — mandates immediate synchronized cardioversion regardless of the rhythm's name. Stable patients are managed by rhythm:

  • Rhythm First-line
  • Regular narrow-complex Vagal maneuvers, then adenosine 6 mg then 12 mg
  • Irregular narrow-complex (AF) Rate control with a beta blocker or non-dihydropyridine calcium blocker

Pre-excited AF (irregular, wide, very fast) Procainamide or ibutilide; cardiovert if unstable. Never adenosine, verapamil, diltiazem, digoxin, or beta blockers

  • Regular wide-complex, presumed VT Amiodarone, procainamide, or sotalol; cardiovert if unstable
  • Torsades de pointes Magnesium sulfate , correct potassium, remove offending drug, overdrive pace if recurrent
  • 6. Emergency Equipment Readiness

Task A1 requires preparing the procedure room, and readiness is checked before every case:

Defibrillator with pacing capability , tested, charged, with pads applied to the patient before draping.

Airway cart: bag-valve-mask, oral and nasal airways, laryngoscope or video device, endotracheal tubes, suction that is on and verified .

Code cart with unexpired drugs, sealed and checked on the current shift.

Pericardiocentesis tray immediately available — in an EP lab it is not "in the hallway", it is in the room.

Protamine drawn up or immediately accessible for any left-sided case.

Temporary pacing generator with fresh batteries and a temporary pacing wire.

Chest tube tray for subclavian access cases.

The single most consequential preparation step is applying defibrillation pads before draping . Once a patient is draped for a device implant, exposing the chest to place pads costs minutes that a VF arrest does not allow.